Rhythio Medical Technologies, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersHouston, TX
SAM.gov UEIRNUMA41BYDM8
Rhythiomedical makes injectable hydrogel electrodes for cardiac rhythm management, designed to restore electrical conduction across scarred heart tissue to enable low-energy defibrillation. The company's injectable electrode system uses a biostable, conductive hydrogel material delivered through the venous system to treat ventricular arrhythmias. The device has received FDA Breakthrough Device Designation.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Rhythio Medical Technologies, INC. | Houston | TX | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.